Official recall notice

FDA DrugClass IINotable

FDA Recall: Isotretinoin Capsules, USP, 40 mg, 10 count Prescription Pacs, Rx only, Manufactured for: Teva Pharm

Recall date
2026-04-15
Category
Drug
FDA class
Class II

Why it was recalled

Hazard

Superpotent and Subpotent

Recommended action

What to do

8376 packages

Product description

Superpotent and Subpotent

Verify with the official notice →
Share:

Related Recalls

2026-09-09 · FDA_DRUG
FDA Recall: traZODone Hydrochloride Tablets, USP, 50 mg, Rx only, 100 Tablets, Manufactured in Croatia By: Pliva
Teva Pharmaceuticals USA, Inc
2026-05-13 · FDA_DRUG
FDA Recall: Octreotide Acetate for Injectable Suspension, for gluteal intramuscular use, 30 mg, In Single-Dose k
Teva Pharmaceuticals USA, Inc
2026-04-29 · FDA_DRUG
FDA Recall: Claravis (isotretinoin capsule, USP), 10 mg, Packaged as a) 100-count carton, NDC 0555-1054-56, with
Teva Pharmaceuticals USA, Inc
2026-04-15 · FDA_DRUG
FDA Recall: Clonidine Transdermal System, USP, 0.3 mg/day, supplied in cartons of 4 Systems and 4 Adhesive Cover
Teva Pharmaceuticals USA, Inc